Concepedia

Author

Gregory G. Schwartz

University of Colorado DenverORCID

Also Known As

Andreas M Zeiher, G G Schwartz, G Schwartz, G. G. Schwartz, G. Schwartz, G.G Schwartz, G.G. Schwartz, GREGORY G. SCHWARTZ, Gregory G Schwartz, Gregory G. Schwartz

370

Publications

22.2K

Citations

64

H-Index

87

Concepts

All Affiliations

University of Colorado DenverSt. Michael's HospitalUniversity of TorontoBrigham and Women's HospitalSUNY Downstate Health Sciences University
GG

About

Gregory G. Schwartz is an author at University of Colorado Denver specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

44

2.5K

2

Public Health

16

18

1.5K

3

Health Sciences

11

11

387

4

Engineering

1

1

15

5

Social Sciences

1

1

52

Gregory G. Schwartz

×

130

Publications

19.2K

Citations

59

H-Index

YearCitations

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek,

New England Journal of Medicine

2018

3.3K

Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>

Gregory G. Schwartz

JAMA

2001

2.5K

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

Gregory G. Schwartz, Anders Olsson, Markus Abt,

New England Journal of Medicine

2012

2K

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

Walter N. Kernan, Catherine M. Viscoli, Karen L. Furie,

New England Journal of Medicine

2016

1.1K

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

Vera Bittner, Michael Szarek, Philip E. Aylward,

Journal of the American College of Cardiology

2020

545

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial

Gregory G. Schwartz, Laurence Bessac, Lisa G. Berdan,

American Heart Journal

2014

409

High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study

Scott Kinlay, Gregory G. Schwartz, Anders Olsson,

Circulation

2003

401

Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome

Stephen J. Nicholls, John J.P. Kastelein, Gregory G. Schwartz,

JAMA

2014

330

Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With Statins

Gregory G. Schwartz, Markus Abt, Weihang Bao,

Journal of the American College of Cardiology

2015

284

Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial

Amy Damask, Philippe Gabríel Steg, Gregory G. Schwartz,

Circulation

2019

232

Page 1